Notícias Abbott Laboratories - ABT | Ações New York Stock Exchange | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NYSE
Abbott Laboratories (ABT)
Abbott Laboratories (ABT) Notícias

Abbott Laboratories (ABT)

118,60

5,23

(4,61%)

Fechado 02 Novembro 5:00PM

Atrasado por 15 minutos

118,88

0,28

(0,24%)

Após o horário de negociação: 8:57PM

Atrasado por 15 minutos

Ferramentas de nível profissional para investidores individuais.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Abbott Initiates New Clinical Trial to Improve Outcomes in Patients with Advanced Heart Failure

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance Range

Abbott Advances Pulsed Field Ablation Clinical Studies and Launches New Technology to Support Advanced Cardiac Mapping

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Abbott and the Big Ten Conference Tackle U.S. Blood Shortages with First-of-its-Kind, Nationwide Blood Donation Competition, 'The We Give Blood Drive'

Abbott Hosts Conference Call for Third-Quarter Earnings

Banco B3 anuncia pagamento de dividendos de R$ 0,167999823 por BDR da Abbott Laboratories

Abbott Declares 403rd Consecutive Quarterly Dividend

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Abbott Laboratories

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições